The Use of Prophylactic Antibiotics for Cesarean Section Delivery and The Incident of Surgical Site Infection

Shofiatul Fajriyah, Umul Farida, Sri Agustina, Lelly Winduhani Astuti, Esti Ambar Widyaningrum

Abstract


According to the 2018 Riskesdas data, the ratio of deliveries by cesarean section in 2018 was recorded at 17.6% of a total of 78,736 deliveries. One of the serious problems in postoperative treatment that has an impact on increasing morbidity, mortality, and increasing medical costs is surgical site infection (SSI). To reduce the risk of infection, efforts are made by giving prophylactic antibiotics followed by surgical procedures. The aim of this study was to determine the use of prophylactic antibiotics in cesarean section surgery and to determine the incidence of surgical site infection (SSI) in patients after Sectio Caesarea surgery in one of a private hospital in Kediri City. This study was an observational descriptive study with retrospective data collection through tracing of medical record data of patients who underwent Caesarean section surgery in 2021. The samples that entered the inclusion criteria were patients who received surgical prophylaxis with antibiotics and returned to the hospital for control after 1 week postoperatively. Samples that met the inclusion criteria were 89 patients. The sampling technique used purposive sampling. This study collected data on prophylactic antibiotics used and the incidence of SSI on days 1, 3 and (7-10) postoperatively.  The results showed that the types of prophylactic antibiotics in patients undergoing sectio caesarea were ceftriaxone 2 g (99%) and cefotaxime 2 g (1%). Whereas there were 3 patients (3%) who had SSI on days 7-10 postoperatively.

Keywords


Prophylactic antibiotic; Cesarian section; Surgical site infection

Full Text:

PDF

References


A. P. Betran, J. Ye, A. B. Moller, J. P. Souza, and J. Zhang, “Trends and projections of caesarean section rates: Global and regional estimates,” BMJ Glob. Health, vol. 6, no. 6, pp. 1–8, 2021, doi: 10.1136/bmjgh-2021-005671.

V. Verma, R. K. Vishwakarma, D. C. Nath, H. T. A. Khan, R. Prakash, and O. Abid, “Prevalence and determinants of caesarean section in South and South-East Asian women,” PLoS ONE, vol. 15, no. 3, pp. 1–15, 2020, doi: 10.1371/journal.pone.0229906.

Kemenkes RI, “Hasil Riset Kesehatan Dasar Tahun 2018,” Kementrian Kesehat. RI, vol. 53, no. 9, pp. 1689–1699, 2018.

K. A. Ban et al., “Executive summary of the American College of Surgeons/Surgical Infection Society Surgical Site Infection Guidelines -2016 Update,” Surg. Infect., vol. 18, no. 4, pp. 379–382, 2017, doi: 10.1089/sur.2016.214.

ECDC, “Surveillance of surgical site infections in Europe,” Stockholm, 2013. doi: 10.2900/90271.

O. Ali, D. Kassahun, B. K. Rade, and A. Atnafu, “Maternal factors are important predictors for surgical site infection following cesarean section in Northwest Ethiopian,” Clin. Epidemiol. Glob. Health, vol. 13, no. August 2021, p. 100936, 2022, doi: 10.1016/j.cegh.2021.100936.

M. M. M. Tsegaw Alemye, Olmessa Oljira, Gelana Fekadu, “Post cesarean section surgical site infection and associated factros among women who delivered in public hospitals in Harar city, Eastern Ehtiophia: A hospital-based analityc cross sectional study,” PLoS ONE, vol. 16, no. 6, 2021.

F. Rivai, T. Koentjoro, and A. Utarini, “Determinant of Surgical Site Infection Post-section Caesarea,” J. Kesehat. Masy. Nas., vol. 8, no. 5, pp. 235–240, 2013.

A. G. Salmanov et al., “Surgical Site Infection After Cesarean Section in Ukraine: Results a Multicenter Study,” Wiadomosci Lek. Wars. Pol. 1960, vol. 74, no. 4, pp. 934–939, 2021, doi: 10.36740/wlek202104123.

F. Broumand, N. Zand Vakili, Z. Yekta, and S. Vazifekhah, “Comparative study of surgical site infection with or without post cesarean prophylactic oral antibiotics; a single-blinded randomized clinical trial,” J. Prev. Epidemiol., vol. 7, no. 1, pp. e07–e07, 2021, doi: 10.34172/jpe.2022.07.

Y. Aulya, S. Novelia, and A. Isnaeni, “Perbedaan Kejadian Infeksi Luka Operasi Antara Elektif SC Dengan Cito Sc Di Rumah Sakit Harapan Jayakarta Tahun 2019,” J. Qual. Womens Health, vol. 4, no. 1, pp. 115–122, 2021, doi: 10.30994/jqwh.v4i1.112.

K. R. Lingam, H. B. Ramineni, S. G. Firdous, P. Yamuna, B. Madhuri, and D. N. S. S. Chidrupi, “Effectiveness and use of prophylactic antibiotics in elective and emergency caesarean section at tertiary care hospital,” Int. J. Reprod. Contracept. Obstet. Gynecol., vol. 9, no. 5, p. 2053, 2020, doi: 10.18203/2320-1770.ijrcog20201804.

Kemenkes RI, Pedoman Penggunaan Antibiotik. Peraturan Menteri Kesehatan Republik Indonesia, 2021, pp. 1–97.

WHO, WHO recommendation on Prophylactic antibiotics for women undergoing caesarean section. 2021, pp. 1–64.

G. Gml, L. Dou, and V. Jc, “Different classes of antibiotics given to women routinely for preventing infection at caesarean section,” Cochrane Database Syst. Rev., no. 11, 2014, doi: 10.1002/14651858.CD008726.pub2.www.cochranelibrary.com.

R. S. Ayuni, A. M. Ulfa, and A. Primadiamanti, “Evaluation Of The Use Prophylaxis Antibiotic In Cesarean Section Patients In The Central Surgical Installation,” Interest J. Ilmu Kesehat., vol. 11, no. 1, pp. 29–36, 2022, doi: 10.37341/interest.v0i0.417.

H. Harahap, A. Purwakanthi, and E. Kusdiyah, “Pengaruh Penggunaan Antibiotik Profilaksis dengan Lama Rawat Inap pada Pasien Seksio Seserea,” Jmj, vol. 8, no. 2, pp. 172–179, 2020.

S. R. Karminingtyas, D. Oktianti, and N. H. Furdiyanti, “Keefektifan Penggunaan Antibiotik Profilaksis Pada Pasien Bedah Sesar (Sectio Caesarea),” Cendekia J. Pharm., vol. 2, no. 1, pp. 22–31, 2018, doi: 10.31596/cjp.v2i1.14.

B. Muzayyanah, Y. Yulistiani, D. Hasmono, and N. Wisudani, “Analysis of Prophylactic Antibiotics Usage in Caesarean Section Delivery,” Folia Medica Indones., vol. 54, no. 3, p. 161, 2018, doi: 10.20473/fmi.v54i3.10004.

S. W. Chandra, S. B. Harsono, A. Eka, and D. Aditya, “BEDAH CESAR DI RSUD IBU FATMAWATI SOEKARNO KOTA SURAKARTA TAHUN 2020,” J. Pharmacopoeia, vol. 2, no. 1, pp. 54–64, 2023.

Fanani Zaenal, Aisah Nur, and Ridwan, “Evaluasi Penggunaan Antibiotik Profilaksis Pada Pasien Operasi Sectio Caesarea Di Rsu Islam Klaten Tahun 2020,” Indones. J. Farm., vol. 1, no. 1, pp. 33–37, 2022.

R. Kumari, A. Sharma, . Sheetal, P. Roy, and . Anupriya, “To study the effectiveness of prophylactic use of ceftriaxone (single dose) in caesarean section in low risk patients in a tertiary care center, Moradabad, India,” Int. J. Res. Med. Sci., vol. 5, no. 12, p. 5278, 2017, doi: 10.18203/2320-6012.ijrms20175440.

M. I. N. A. Wibowo, T. D. Utamiasih, and D. R. Juwita, “Evaluasi Penggunaan Antibiotik Profilaksis pada Operasi Sesar di Rumah Sakit Swasta Purwokerto,” Pharm. J. Farm. Indones. Pharm. J. Indones., vol. 16, no. 2, p. 372, 2019, doi: 10.30595/pharmacy.v16i2.5560.

C. Saleh and M. Kurniasari, “Pola Peresepan Antibiotik Profilaksis Pre Bedah Sectio Caesarea Di Rumah Sakit BR Jakarta Selatan,” J. Ris. Kefarmasian Indones., vol. 3, no. 1, pp. 65–76, 2021, doi: 10.33759/jrki.v3i1.117.

R. Tampa’i, N. Ngala, and D. Wua, “Evaluasi Penggunaan Antibiotik Profilaksis pada Pasien Bedah Sesar di Instalasi Bedah sentral Rumah Sakit XY Manado,” J. Farm. Politek. Indonusa Surak., vol. 4, pp. 8–12, 2020.

M. S. A. R. Nita Rusdiana, “Evaluasi penggunaan Antibiotika Profilaksis pada pasien bedah sesar terencana di Rumah Sakit Ibu dan Anak ‘X’ di Tanggerang,” Soc. Clin. Pharm. Indones. J., vol. 1, 2016.

Y. H. Ninik Mas Ulfa, Selly Septi Fandinata, “ANALISIS EFEKTIFITAS CEFAZOLINE, CEFTRIAXONE, CEFOTAXIME SEBAGAI ANTIBIOTIK PROFILAKSIS PADA PASIEN SECTIO CAESAREA,” -Syifaa J. Farm., vol. 11, no. 02, pp. 103–111, 2019.

T. Kawakita and H. J. Landy, “Surgical site infections after cesarean delivery: epidemiology, prevention and treatment,” Matern. Health Neonatol. Perinatol., vol. 3, no. 1, pp. 1–10, 2017, doi: 10.1186/s40748-017-0051-3.

R. Kartikasari and N. Apriningrum, “Determinan Terjadinya Infeksi Luka Operasi (ILO) Post Sectio Caesarea,” Faletehan Health J., vol. 7, no. 03, pp. 162–169, 2020, doi: 10.33746/fhj.v7i03.195.

Murniati, Zulkarnaini, and Z. Juwita, “Faktor-faktor Yang Mempengaruhi Terjadinya Infeksi Luka Post Sectio Caesarea,” Darussalam Indones. J. Nurs. Midwifery, vol. 1, no. 1, pp. 21–31, 2020.

P. Sumarningsih, N. M. Yasin, and R. H. Asdie, “Pengaruh faktor resiko terhadap kejadian ILO pada pasien bedah obstetri dan ginekologi di RSUP Dr . Sardjito Yogyakarta,” Maj. Farm., vol. 16, no. 1, pp. 43–49, 2020, doi: 10.22146/farmaseutik.v16i1.47986.




DOI: https://doi.org/10.37311/ijpe.v3i2.19864

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Shofiatul Fajriyah, Umul Farida, Sri Agustina, Lelly Winduhani Astuti, Esti Ambar Widyaningrum

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.